Soleno Therapeutics (SLNO) Research & Development: 2013-2017
Historic Research & Development for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to $1.0 million.
- Soleno Therapeutics' Research & Development rose 255.03% to $1.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.1 million, marking a year-over-year decrease of 10.42%. This contributed to the annual value of $78.6 million for FY2024, which is 211.91% up from last year.
- Per Soleno Therapeutics' latest filing, its Research & Development stood at $1.0 million for Q4 2017, which was up 8.14% from $946,000 recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' Research & Development registered a high of $1.8 million during Q1 2016, and its lowest value of $288,141 during Q4 2016.
- In the last 3 years, Soleno Therapeutics' Research & Development had a median value of $912,000 in 2015 and averaged $919,282.
- Data for Soleno Therapeutics' Research & Development shows a peak YoY increase of 255.03% (in 2017) and a maximum YoY decrease of 81.55% (in 2017) over the last 5 years.
- Over the past 5 years, Soleno Therapeutics' Research & Development (Quarterly) stood at $359,832 in 2013, then skyrocketed by 69.31% to $609,216 in 2014, then soared by 110.80% to $1.3 million in 2015, then tumbled by 77.56% to $288,141 in 2016, then skyrocketed by 255.03% to $1.0 million in 2017.
- Its Research & Development was $1.0 million in Q4 2017, compared to $946,000 in Q3 2017 and $773,000 in Q2 2017.